Sandbox:Qurrat: Difference between revisions
Line 1,181: | Line 1,181: | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Schwannoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Schwannoma | ||
<ref name="pmid24450866">{{cite journal |vauthors=Hilton DA, Hanemann CO |title=Schwannomas and their pathogenesis |journal=Brain Pathol. |volume=24 |issue=3 |pages=205–20 |date=April 2014 |pmid=24450866 |doi=10.1111/bpa.12125 |url=}}</ref><ref name="pmid28237565">{{cite journal |vauthors=Albert P, Patel J, Badawy K, Weissinger W, Brenner M, Bourhill I, Parnell J |title=Peripheral Nerve Schwannoma: A Review of Varying Clinical Presentations and Imaging Findings |journal=J Foot Ankle Surg |volume=56 |issue=3 |pages=632–637 |date=2017 |pmid=28237565 |doi=10.1053/j.jfas.2016.12.003 |url=}}</ref><ref name="pmid27020268">{{cite journal |vauthors=Wong BLK, Bathala S, Grant D |title=Laryngeal schwannoma: a systematic review |journal=Eur Arch Otorhinolaryngol |volume=274 |issue=1 |pages=25–34 |date=January 2017 |pmid=27020268 |doi=10.1007/s00405-016-4013-6 |url=}}</ref> | <ref name="pmid24450866">{{cite journal |vauthors=Hilton DA, Hanemann CO |title=Schwannomas and their pathogenesis |journal=Brain Pathol. |volume=24 |issue=3 |pages=205–20 |date=April 2014 |pmid=24450866 |doi=10.1111/bpa.12125 |url=}}</ref><ref name="pmid28237565">{{cite journal |vauthors=Albert P, Patel J, Badawy K, Weissinger W, Brenner M, Bourhill I, Parnell J |title=Peripheral Nerve Schwannoma: A Review of Varying Clinical Presentations and Imaging Findings |journal=J Foot Ankle Surg |volume=56 |issue=3 |pages=632–637 |date=2017 |pmid=28237565 |doi=10.1053/j.jfas.2016.12.003 |url=}}</ref><ref name="pmid27020268">{{cite journal |vauthors=Wong BLK, Bathala S, Grant D |title=Laryngeal schwannoma: a systematic review |journal=Eur Arch Otorhinolaryngol |volume=274 |issue=1 |pages=25–34 |date=January 2017 |pmid=27020268 |doi=10.1007/s00405-016-4013-6 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Benign | ||
| align="center" style="background:#F5F5F5;" |Rare tumor | | align="center" style="background:#F5F5F5;" |Rare tumor | ||
Line 1,194: | Line 1,194: | ||
* Decrease sweating | * Decrease sweating | ||
* Dropping eye lid | * Dropping eye lid | ||
* Vestibular Schwannoma( most common): | |||
* hearing impairment | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | +/- | | align="center" style="background:#F5F5F5;" | +/- | ||
Line 1,199: | Line 1,201: | ||
| align="center" style="background:#F5F5F5;" |Noirmal | | align="center" style="background:#F5F5F5;" |Noirmal | ||
| align="center" style="background:#F5F5F5;" | - | | align="center" style="background:#F5F5F5;" | - | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Associated with neurofibromatosis type II. | ||
Most common nerve involved in vestibular nerve. | |||
| align="center" style="background:#F5F5F5;" |May be normal | | align="center" style="background:#F5F5F5;" |May be normal | ||
| align="center" style="background:#F5F5F5;" |It is a peripheral nerve tumor | | align="center" style="background:#F5F5F5;" |It is a peripheral nerve tumor | ||
Line 1,210: | Line 1,214: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Lymphoma 7139563 | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Benign/ malignnat | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Age: Predilection for older age | ||
Mean age: | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Insidious onset slow growing lymph nodes with non-specific systemic B symptoms (fever, night sweats, weight loss) | |||
* Skin rash | |||
* Waxing and waning lymphadenopathy | |||
* Abdominal fullness ( hepatomegaly and spleenomegaly) | |||
* Infections (cytopenias) | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Skin rash and pruritus | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Raised LDH levels | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | |
Revision as of 18:15, 8 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
tab
Differential diagnosis of neck masses
Differential diagnosis of neck masses include:
Category | Diseases | Benign or Malignant | Clinical manifestation | Paraclinical findings | Gold standard diagnosis | Associated findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Lab findings | Histopathology | Imaging | ||||||||||
Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | |||||||||||
Congenital | Branchial cleft cyst[1] |
|
|
|
- | +/- |
|
|
- | - | - |
|
|
| ||
Thyroglossal duct cyst[2][3] |
|
|
|
- | - |
|
- | - | - | - |
|
|
- | |||
Haemangioma[4] |
|
|
|
- | - |
|
|
- | - |
|
|
|
| |||
Vascular malformations | ||||||||||||||||
Lymphatic malformations | ||||||||||||||||
Laryngocele[5][6][7] |
|
|
|
- | +/- |
|
- | - |
|
- |
|
|
|
- | ||
Ranula[8] |
|
|
|
- | - |
|
- | |||||||||
Teratoma | Incidence: 1:4000 births | High ALP levels | ||||||||||||||
Dermoid cyst[9][10] |
|
|
|
- | - |
|
|
- | - |
|
|
|||||
Thymic cyst[11] |
|
|
|
- | - |
|
- | - |
|
|
||||||
Category | Diseases | Benign or Malignant | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Inflammatory | Acute sialadenitis [12] |
|
|
|
+ | - |
|
|
+ |
|
|
|
||||
Chronic sialadenitis |
|
|
|
+ | - |
|
|
|
||||||||
Reactive viral lymphadenopathy | CMV[13] |
|
|
- | - |
|
|
|
|
|||||||
EBV[14][15] |
|
|
- | - |
|
|
|
|
|
|||||||
HIV |
|
|||||||||||||||
Viral URI | ||||||||||||||||
Bacterial lymphadenopathy | Tularemia | |||||||||||||||
Brucellosis | ||||||||||||||||
Cat-scratch disease | ||||||||||||||||
Actinomycosis | ||||||||||||||||
Mycobacterial infections | ||||||||||||||||
Staphylococcal or streptococcal infection | ||||||||||||||||
Parasitic lymphadenopathy | Toxoplasma gondii | |||||||||||||||
Sarcoidosis | ||||||||||||||||
Amyloidosis | ||||||||||||||||
Sjögren syndrome | ||||||||||||||||
Castleman disease (angiofollicular lymphoproliferative disease) | ||||||||||||||||
Kikuchi disease (histiocytic necrotizing lymphadenitis) | ||||||||||||||||
Kimura disease | ||||||||||||||||
Rosai-Dorfman disease | ||||||||||||||||
Kawasaki disease | ||||||||||||||||
Category | Diseases | Benign or Malignant | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Neoplasm | Primary thyroid tumor | |||||||||||||||
Salivary gland neoplasm | Pleomorphic adenoma | + | ||||||||||||||
Warthin's tumor | + | |||||||||||||||
Lymphoepithelioma | + | |||||||||||||||
Oncocytoma | Benign |
|
|
+/- | +/- | Firm, multilobulated and mobile mass |
|
- |
|
Epithelial cells with eosinophilic granular cytoplasm rich in mitochondria |
|
Incisional biopsy and histopathological examination | ||||
Monomorphic adenoma [17][18][19] | Benign or malignant |
|
|
+/- | +/- | Nodular and fluctuant swelling |
|
+/- | Normal |
|
Ultrasound:
CT:
MRI:
|
Incisional biopsy and histopathological examination | ||||
Mucoepidermoid carcinoma | Malignant |
|
|
+/- | +/- | Cystic and solid mass | Normal | +/- | Association with CMV | Gross findings:
Microscopic:
|
cystic and solid component with variable appearance | Incisional biopsy and histopathological examination | ||||
Adenoid cystic carcinoma [21] | Malignant | Age: 40s to 60s
Gender: Female predominance |
Slow growing painless mass | +/- | +/- | Solid mass | Normal to ulcerated lesions | +/- | Slow growing rare tumor with low recurrence | Gross: Tubular, cribriform and solid pattern of growrth
Microscopic: Components of large cells with pleomorphic nuclei increased mitotic activity, and focial necrosis. |
Imaging reveal dimensions of the tumor, local spread and distant metastasis | Biopsy and histopathological examination | ||||
Adenocarcinoma | Malignant | Age: young age predilection | Its a tumor of minor salivary glands so may present as small ulceration or nodules in oral cavity | - | - | Small nodules and oral cavity with or without lymphadenopathy | Skin stays intact or may show some ulceration | +/- | There are several subtypes of adenocarcimoma.
Some are more infiltrating in nature |
Can be normal or may show anemia and blood cell disorders with distant bone invasion | On histology it is confused with Adeocyctic carcinoma with components of gland and cyst formations.
It has more perineural invasion. |
CT and MRI both can be used to visualize the tumor. MRI being more accurate for adjacent tissue involvement and lymphadenopathy. | Biopsy and histopathological examination | |||
Salivary duct carcinoma | Malignant
(Highly aggressive) |
Incidence: 1% to 3%
Gender: Men Mean age: 55 to 61 years |
Presents as rapidly growing mass | +/- | +/- |
|
Jaw involvement results in ulceration of mucosa and may cause ulceration of skin as well | +/- | Rapidly growing mass with jaw involvement and facial paralysis in case of facial nerve involvement | Pathomorphologically tumor of salivary ducts resembles tumor of breast ducts , and that where it name is derived from | Gross findings:
Microscopic finding:
|
Non-specific features on CT and MRI but it can show neural and jaw involvement. | Biopsy and histopathological examination | |||
Squamous cell carcinoma | Malignant | Incidence: rare tumor
Age: Old age , 61 to 68 years Gender: Male predilection |
Present as painful growing mass on jaw | + | - |
|
Thinning and discoloration of skin | - | Submandibular gland predilection | Past radiation exposure is a strong risk factor. | Gross: Shows skin tissue and thinning of skin
Microscopically: Nest and solid sheets of tumor cells arranged in glandular pattern. It is derived from epidermoid cells of salivary gland. May show vascular invasion and inflammatory infiltrate. Immunohistochemical staining can be used to mark the squamous and keratin component. |
Tumor dimension can be delineated using both CT and MRI | Biopsy and histopathological examination | |||
Parathyroid tumors | Malignant | Incidence: Rare
Mean age : 44 to 54 years Gender: Female predilection |
|
+ | + | Lower neck mass with | Skin stays intact most of the time | - | Labs may show hypercalcemia and its consequences such as pancreatitis and decrease bone density on DEXA scan. |
|
Microscopic findings:Tumor shows trabecular growth pattern with high mitosis and surrounding thick fibrous bands. Capsular involvement and vascular invasion is common |
|
Biopsy and histopathological examination | |||
Carotid body tumors |
|
- | - | - | ||||||||||||
Paraganglioma | Benign (Majority)
Malignnat (rare) |
Mean age:age from 50 to 70 years
Gender: More in females |
May be an accidental finding depending on their secretory nature may present with following symptoms:
Catecholamine-secreting paragangliomas present with :
|
- | - | No visible mass as they are located deep in the the neck along the glossopharyngeal and vagal nerves. | skin stays intact and usually is normal | - | Associated with some hereditary syndromes and MEN2B syndrome, Neurofibromatosis type 1 and VHL disease. | Biochemical testing may show catecholamine metabolites in serum or urine samples | These are highly vascular tumors that involves nerves around vessels
Gross findings:
Microscopic findings: Round or polygonal cells arranged inside capsule in the form of nests or forming trabecular structures. Differentiation between benign or malignancy form is done depending microscopic features of invasion and high mitotic index.. |
Following imaging techniques can be used to diagnose the tumor:
As these are secretory tumors further testing with following techniques can confirm diagnoses:
|
Imaging and serum catecholamine analysis | |||
Schwannoma | Benign | Rare tumor
Incidence: 1% to 10% |
Slow growing mass presents with the localized neural deficit depending on the site of peripheral nerve involved.
Vagal involvement:
Sympathetic nerve involvement may present as Horner's syndrome:
|
+ | +/- | Multiple slow growing nodules on the skin | Noirmal | - | Associated with neurofibromatosis type II.
Most common nerve involved in vestibular nerve. |
May be normal | It is a peripheral nerve tumor
vagus nerve or superior cervical sympathetic chain being most common locations. Histology shows encapsulated neural tissue growth. |
Imaging can diagnose the tumor. Its hard to discriminate Carotid body tumor from Schwannoma on CT.MRI and MRI angiography can confirm the diagnoses. | Imaging is used for diagnose | |||
Lymphoma 7139563 | Benign/ malignnat | Age: Predilection for older age
Mean age: |
|
Skin rash and pruritus | Raised LDH levels | |||||||||||
Liposarcoma | ||||||||||||||||
Lipoma | ||||||||||||||||
Glomus vagale, glomus jugulare tumors | ||||||||||||||||
Metastatic head and neck carcinoma | ||||||||||||||||
Other | Hematoma | |||||||||||||||
Arteriovenous fistula | ||||||||||||||||
Goiter | ||||||||||||||||
Category | Diseases | Benign | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings |
References
- ↑ Nahata, Vaishali (2016). "Branchial cleft cyst". Indian Journal of Dermatology. 61 (6): 701. doi:10.4103/0019-5154.193718. ISSN 0019-5154.
- ↑ Amos J, Shermetaro C. PMID 30085599. Missing or empty
|title=
(help) - ↑ Deaver MJ, Silman EF, Lotfipour S (August 2009). "Infected thyroglossal duct cyst". West J Emerg Med. 10 (3): 205. PMC 2729228. PMID 19718389.
- ↑ Léauté-Labrèze, C.; Prey, S.; Ezzedine, K. (2011). "Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities". Journal of the European Academy of Dermatology and Venereology. 25 (11): 1245–1253. doi:10.1111/j.1468-3083.2011.04102.x. ISSN 0926-9959.
- ↑ Werner RL, Schroeder JW, Castle JT (March 2014). "Bilateral laryngoceles". Head Neck Pathol. 8 (1): 110–3. doi:10.1007/s12105-013-0478-4. PMC 3950389. PMID 23881550.
- ↑ Prasad KC, Vijayalakshmi S, Prasad SC (December 2008). "Laryngoceles - presentations and management". Indian J Otolaryngol Head Neck Surg. 60 (4): 303–8. doi:10.1007/s12070-008-0108-8. PMC 3476818. PMID 23120570.
- ↑ Mahdoufi R, Barhmi I, Tazi N, Abada R, Roubal M, Mahtar M (July 2017). "Mixed Pyolaryngocele: A Rare Case of Deep Neck Infection". Iran J Otorhinolaryngol. 29 (93): 225–228. PMC 5554815. PMID 28819622.
- ↑ Packiri S, Gurunathan D, Selvarasu K (September 2017). "Management of Paediatric Oral Ranula: A Systematic Review". J Clin Diagn Res. 11 (9): ZE06–ZE09. doi:10.7860/JCDR/2017/28498.10622. PMC 5713871. PMID 29207849.
- ↑ Paradis, Josée; Koltai, Peter J. (2015). "Pediatric Teratoma and Dermoid Cysts". Otolaryngologic Clinics of North America. 48 (1): 121–136. doi:10.1016/j.otc.2014.09.009. ISSN 0030-6665.
- ↑ Gaddikeri S, Vattoth S, Gaddikeri RS, Stuart R, Harrison K, Young D, Bhargava P (2014). "Congenital cystic neck masses: embryology and imaging appearances, with clinicopathological correlation". Curr Probl Diagn Radiol. 43 (2): 55–67. doi:10.1067/j.cpradiol.2013.12.001. PMID 24629659.
- ↑ Gaddikeri, Santhosh; Vattoth, Surjith; Gaddikeri, Ramya S.; Stuart, Royal; Harrison, Keith; Young, Daniel; Bhargava, Puneet (2014). "Congenital Cystic Neck Masses: Embryology and Imaging Appearances, With Clinicopathological Correlation". Current Problems in Diagnostic Radiology. 43 (2): 55–67. doi:10.1067/j.cpradiol.2013.12.001. ISSN 0363-0188.
- ↑ Abdel Razek A, Mukherji S (June 2017). "Imaging of sialadenitis". Neuroradiol J. 30 (3): 205–215. doi:10.1177/1971400916682752. PMC 5480791. PMID 28059621. Vancouver style error: initials (help)
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Stuhlmann-Laeisz C, Oschlies I, Klapper W (December 2014). "Detection of EBV in reactive and neoplastic lymphoproliferations in adults-when and how?". J Hematop. 7 (4): 165–170. doi:10.1007/s12308-014-0209-0. PMC 4243011. PMID 25478033.
- ↑ Chen B, Hentzelman JI, Walker RJ, Lai JP (2016). "Oncocytoma of the Submandibular Gland: Diagnosis and Treatment Based on Clinicopathology". Case Rep Otolaryngol. 2016: 8719030. doi:10.1155/2016/8719030. PMC 5045990. PMID 27722003.
- ↑ Kim KH, Sung MW, Kim JW, Koo JW (July 2000). "Pleomorphic adenoma of the trachea". Otolaryngol Head Neck Surg. 123 (1 Pt 1): 147–8. doi:10.1067/mhn.2000.102809. PMID 10889498.
- ↑ Pramod Krishna B (June 2013). "Pleomorphic Adenoma of Minor Salivary Gland in a 14 year Old Child". J Maxillofac Oral Surg. 12 (2): 228–31. doi:10.1007/s12663-010-0125-5. PMC 3681990. PMID 24431845.
- ↑ Kessler AT, Bhatt AA (2018). "Review of the Major and Minor Salivary Glands, Part 2: Neoplasms and Tumor-like Lesions". J Clin Imaging Sci. 8: 48. doi:10.4103/jcis.JCIS_46_18. PMC 6251244. PMID 30546932.
- ↑ Chenevert J, Barnes LE, Chiosea SI (February 2011). "Mucoepidermoid carcinoma: a five-decade journey". Virchows Arch. 458 (2): 133–40. doi:10.1007/s00428-011-1040-y. PMID 21243374.
- ↑ Jones AV, Craig GT, Speight PM, Franklin CD (April 2008). "The range and demographics of salivary gland tumours diagnosed in a UK population". Oral Oncol. 44 (4): 407–17. doi:10.1016/j.oraloncology.2007.05.010. PMID 17825603.
- ↑ Beltran D, Faquin WC, Gallagher G, August M (March 2006). "Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma". J. Oral Maxillofac. Surg. 64 (3): 415–23. doi:10.1016/j.joms.2005.11.027. PMID 16487803.
- ↑ Mlika M, Kourda N, Zidi Y, Aloui R, Zneidi N, Rammeh S, Zermani R, Jilani SB (January 2012). "Salivary duct carcinoma of the parotid gland". J Oral Maxillofac Pathol. 16 (1): 134–6. doi:10.4103/0973-029X.92992. PMC 3303509. PMID 22434951.
- ↑ Schmitt NC, Kang H, Sharma A (November 2017). "Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy". Oral Oncol. 74: 40–48. doi:10.1016/j.oraloncology.2017.09.008. PMC 5685667. PMID 29103750.
- ↑ Simpson RH (July 2013). "Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification". Head Neck Pathol. 7 Suppl 1: S48–58. doi:10.1007/s12105-013-0456-x. PMC 3712088. PMID 23821208.
- ↑ Manvikar V, Ramulu S, Ravishanker ST, Chakravarthy C (May 2014). "Squamous cell carcinoma of submandibular salivary gland: A rare case report". J Oral Maxillofac Pathol. 18 (2): 299–302. doi:10.4103/0973-029X.140909. PMC 4196305. PMID 25328317.
- ↑ Ying YL, Johnson JT, Myers EN (July 2006). "Squamous cell carcinoma of the parotid gland". Head Neck. 28 (7): 626–32. doi:10.1002/hed.20360. PMID 16475198.
- ↑ Wei CH, Harari A (March 2012). "Parathyroid carcinoma: update and guidelines for management". Curr Treat Options Oncol. 13 (1): 11–23. doi:10.1007/s11864-011-0171-3. PMID 22327883.
- ↑ Sahasranam P, Tran MT, Mohamed H, Friedman TC (August 2007). "Multiglandular parathyroid carcinoma: a case report and brief review". South. Med. J. 100 (8): 841–4. doi:10.1097/SMJ.0b013e318073ca37. PMID 17713315.
- ↑ Holmes EC, Morton DL, Ketcham AS (April 1969). "Parathyroid carcinoma: a collective review". Ann. Surg. 169 (4): 631–40. PMC 1387475. PMID 4886854.
- ↑ Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C (August 2004). "Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations". JAMA. 292 (8): 943–51. doi:10.1001/jama.292.8.943. PMID 15328326.
- ↑ Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF (November 2001). "Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients". J. Clin. Endocrinol. Metab. 86 (11): 5210–6. doi:10.1210/jcem.86.11.8034. PMID 11701678.
- ↑ O'Riordain DS, Young WF, Grant CS, Carney JA, van Heerden JA (September 1996). "Clinical spectrum and outcome of functional extraadrenal paraganglioma". World J Surg. 20 (7): 916–21, discussion 922. PMID 8678971.
- ↑ Hilton DA, Hanemann CO (April 2014). "Schwannomas and their pathogenesis". Brain Pathol. 24 (3): 205–20. doi:10.1111/bpa.12125. PMID 24450866.
- ↑ Albert P, Patel J, Badawy K, Weissinger W, Brenner M, Bourhill I, Parnell J (2017). "Peripheral Nerve Schwannoma: A Review of Varying Clinical Presentations and Imaging Findings". J Foot Ankle Surg. 56 (3): 632–637. doi:10.1053/j.jfas.2016.12.003. PMID 28237565.
- ↑ Wong B, Bathala S, Grant D (January 2017). "Laryngeal schwannoma: a systematic review". Eur Arch Otorhinolaryngol. 274 (1): 25–34. doi:10.1007/s00405-016-4013-6. PMID 27020268. Vancouver style error: initials (help)
Diseases | Clinical manifestations | Para-clinical findings | Pap Smear | Histopathology | Gold standard | Additional findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | ||||||||||||||
Menorrhagia | Post Menstrual
Bleeding |
Pelvic Pain | Other
symptoms |
Pelvic examination | Abdominal examination | Hb | B-HCG | CEA-19 | Ultrasound | MRI | |||||
Endometrial cancer | + | + | ↓ | + | |||||||||||
Uterine | +/- | + | ↓ | + | |||||||||||
Uterine | +/- | +/- | ↓
or N |
||||||||||||
Uterine leiomyoma | +/- | +/- | ↓
or N |
||||||||||||
Malignant mixed
Mullerian tumour (MMMT) of the uterus |
+/- | +/- | ↓ | ||||||||||||
Cervical cancer
with uterine invasion |
+ | + | ↓ | ||||||||||||
Metastasis to the uterus from a
non-gynaecologcial malignancy |
+ | + | ↓ | ||||||||||||
Endometrial | + | + | ↓ | +
or N |
|||||||||||
Endometrial | + | + | ↓ | + | |||||||||||
Uterine | - | - | ↓ | + | |||||||||||
Hematometra | - | - | ↓ | + | |||||||||||
Gestational | |||||||||||||||
Incomplete | |||||||||||||||
Fetus | No
Menstrual cycle |
+/- | - | ||||||||||||
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
Uterine cancer | |||||||||||||||
Uterine sarcoma | |||||||||||||||
Infection | |||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Abscess | |||||||||||||||
Septic emboli | |||||||||||||||
Fungi | |||||||||||||||
Differential Diagnosis 1 | |||||||||||||||
Differential Diagnosis 2 | |||||||||||||||
Differential Diagnosis 3 | |||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Differential Diagnosis 4 | |||||||||||||||
Differential Diagnosis 5 | |||||||||||||||
Differential Diagnosis 6 |
Table for Differential Diagnosis of Small Intestine Cancer
ABBREVIATIONS:
N/A: Not available, NL: Normal,